Association between serum vitamin A levels and premature ovarian insufficiency: a case-control, cross-sectional survey study.
Anti-Müllerian hormone
Premature ovarian insufficiency
Retinoid signaling
Vitamin A
Journal
BMC endocrine disorders
ISSN: 1472-6823
Titre abrégé: BMC Endocr Disord
Pays: England
ID NLM: 101088676
Informations de publication
Date de publication:
04 Apr 2022
04 Apr 2022
Historique:
received:
08
07
2021
accepted:
24
03
2022
entrez:
5
4
2022
pubmed:
6
4
2022
medline:
7
4
2022
Statut:
epublish
Résumé
Although vitamin A is known to play an important role in ovarian function, its association with ovarian insufficiency has not been reported yet. Therefore, the aim of the study was to explore the association between serum vitamin A levels and premature ovarian insufficiency (POI). This cross-sectional survey included women with POI (n = 47) and normo-ovulatory controls (n = 67) who were enrolled between December 2016 and May 2018 in Zhejiang, China. The serum levels of follicle-stimulating hormone (FSH), luteinizing hormone (LH), estradiol (E Serum vitamin A levels appeared to be slightly higher in the POI group than in the control group, but there was no evidence of a statistically significant difference (728.00 ± 176.00 µg/L vs. 503.93 ± 145.64 µg/L, p = 0.13). After adjustment for serum lipid levels, the serum vitamin A/TC ratio was significantly lower in the POI group than in the control group (143.14 ± 35.86 vs. 157.56 ± 35.21 µg/mmol, p = 0.04). Further, the serum vitamin A/TC ratio was significantly and inversely associated with POI risk (unadjusted odds ratio [OR] = 0.988, 95% confidence interval [CI]: 0.977-0.999, p = 0.04). The association remained after adjusting for confounding factors (age, BMI, annual household income, and education) (OR = 0.986, 95% CI: 0.972-0.999, p = 0.04). Serum vitamin A/TC ratio was inversely associated with POI risk. Therefore, the serum vitamin A/TC ratio may serve as a predictive factor for POI, and vitamin A supplementation may play help prevent or treat POI.
Sections du résumé
BACKGROUND
BACKGROUND
Although vitamin A is known to play an important role in ovarian function, its association with ovarian insufficiency has not been reported yet. Therefore, the aim of the study was to explore the association between serum vitamin A levels and premature ovarian insufficiency (POI).
METHODS
METHODS
This cross-sectional survey included women with POI (n = 47) and normo-ovulatory controls (n = 67) who were enrolled between December 2016 and May 2018 in Zhejiang, China. The serum levels of follicle-stimulating hormone (FSH), luteinizing hormone (LH), estradiol (E
RESULTS
RESULTS
Serum vitamin A levels appeared to be slightly higher in the POI group than in the control group, but there was no evidence of a statistically significant difference (728.00 ± 176.00 µg/L vs. 503.93 ± 145.64 µg/L, p = 0.13). After adjustment for serum lipid levels, the serum vitamin A/TC ratio was significantly lower in the POI group than in the control group (143.14 ± 35.86 vs. 157.56 ± 35.21 µg/mmol, p = 0.04). Further, the serum vitamin A/TC ratio was significantly and inversely associated with POI risk (unadjusted odds ratio [OR] = 0.988, 95% confidence interval [CI]: 0.977-0.999, p = 0.04). The association remained after adjusting for confounding factors (age, BMI, annual household income, and education) (OR = 0.986, 95% CI: 0.972-0.999, p = 0.04).
CONCLUSIONS
CONCLUSIONS
Serum vitamin A/TC ratio was inversely associated with POI risk. Therefore, the serum vitamin A/TC ratio may serve as a predictive factor for POI, and vitamin A supplementation may play help prevent or treat POI.
Identifiants
pubmed: 35379206
doi: 10.1186/s12902-022-01003-9
pii: 10.1186/s12902-022-01003-9
pmc: PMC8981733
doi:
Substances chimiques
Vitamin A
11103-57-4
Follicle Stimulating Hormone
9002-68-0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
88Informations de copyright
© 2022. The Author(s).
Références
Health Soc Work. 2017 May 1;42(2):79-86
pubmed: 28340231
Climacteric. 2015;18(4):483-91
pubmed: 25845383
Fertil Steril. 2008 Jan;89(1):129-40
pubmed: 17681300
Ann N Y Acad Sci. 1972 Dec 18;203:223-36
pubmed: 4633111
Ann Nutr Metab. 2015;66 Suppl 2:22-33
pubmed: 26045325
Semin Cell Dev Biol. 1997 Aug;8(4):429-35
pubmed: 15001081
Endocrinology. 2016 May;157(5):2160-72
pubmed: 27022678
Prz Menopauzalny. 2018 Sep;17(3):105-108
pubmed: 30357004
Epigenetics. 2018;13(8):875-895
pubmed: 30207508
Hum Reprod. 2016 May;31(5):926-37
pubmed: 27008889
Biomolecules. 2019 Nov 24;9(12):
pubmed: 31771306
PLoS One. 2020 Mar 5;15(3):e0229576
pubmed: 32134933
J Assist Reprod Genet. 2011 Jun;28(6):553-8
pubmed: 21681498
Syst Biol Reprod Med. 2020 Apr;66(2):112-121
pubmed: 32057251
Environ Sci Technol. 2018 Mar 6;52(5):3240-3248
pubmed: 29444570
Ann Clin Biochem. 1986 Sep;23 ( Pt 5):514-20
pubmed: 3767286
Ann N Y Acad Sci. 2008;1135:146-54
pubmed: 18574220
Biol Reprod. 2009 Nov;81(5):996-1001
pubmed: 19587328
Iran J Reprod Med. 2015 Sep;13(9):533-40
pubmed: 26568757
Clin Chem. 1995 Jun;41(6 Pt 1):924-7
pubmed: 7768014
Animals (Basel). 2019 Aug 15;9(8):
pubmed: 31443306